Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$0.16 - $1.64 $15,916 - $163,139
99,475 New
99,475 $17,000
Q3 2021

Nov 12, 2021

SELL
$1.69 - $2.89 $18,671 - $31,928
-11,048 Closed
0 $0
Q2 2021

Aug 12, 2021

SELL
$2.64 - $6.32 $88,503 - $211,871
-33,524 Reduced 75.21%
11,048 $29,000
Q1 2021

May 14, 2021

BUY
$1.35 - $4.99 $60,172 - $222,414
44,572 New
44,572 $222,000

Others Institutions Holding SEEL

# of Institutions
1
Shares Held
40.5K
Call Options Held
0
Put Options Held
0

About SEELOS THERAPEUTICS, INC.


  • Ticker SEEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 106,691,000
  • Market Cap $59.7M
  • Description
  • Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...
More about SEEL
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.